Artykuły w czasopismach na temat „Fluorouracil – Analyse”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Fluorouracil – Analyse”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Kadziauskienė, Aistė, Ernesta Strelkauskaitė, Eglė Mockevičiūtė, Rimvydas Ašoklis, Eugenijus Lesinskas i Leopold Schmetterer. "Changes in macular thickness after trabeculectomy with or without adjunctive 5-fluorouracil". Acta medica Lituanica 24, nr 2 (17.07.2017): 93–100. http://dx.doi.org/10.6001/actamedica.v24i2.3489.
Pełny tekst źródłaEngelman, Dan, Michel Moreau, Antonia Lepida, Yasmine Zaouak, Marianne Paesmans i Ahmad Awada. "Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity". ESMO Open 5, nr 3 (czerwiec 2020): e000695. http://dx.doi.org/10.1136/esmoopen-2020-000695.
Pełny tekst źródłaThomas, Ritty Ann, i Vasim Ismail Patel. "A comparative analysis between intralesional 5-fluorouracil versus surgical excision with intralesional triamcinalone acetonide in keloid excision". International Journal of Otorhinolaryngology and Head and Neck Surgery 6, nr 5 (21.04.2020): 904. http://dx.doi.org/10.18203/issn.2454-5929.ijohns20201684.
Pełny tekst źródłaZhang, Cong, Hongpeng Liu, Bin Ma, Yongxi Song, Peng Gao, Yingying Xu, Dehao Yu i Zhenning Wang. "The Impact of the Expression Level of Intratumoral Dihydropyrimidine Dehydrogenase on Chemotherapy Sensitivity and Survival of Patients in Gastric Cancer: A Meta-Analysis". Disease Markers 2017 (2017): 1–11. http://dx.doi.org/10.1155/2017/9202676.
Pełny tekst źródłaIzyumov, Mikhail Sergeevich, Viktor Viktorovich Bulynin, Andrey Mikhailovich Bobrovskih i Olga Gennadevna Deryaeva. "Comparative Assessment of Morphological Changes in the Pleura and Lung Tissue after Pleurodesis with Various Solutions in the Experiment". Journal of Experimental and Clinical Surgery 15, nr 2 (24.06.2022): 147–53. http://dx.doi.org/10.18499/2070-478x-2022-15-2-147-153.
Pełny tekst źródłaMohan, Ambikavathy, i Chandan Kumar. "Clinical profile and management of breast cancer in women in a rural based tertiary care hospital our experience". International Surgery Journal 4, nr 2 (25.01.2017): 697. http://dx.doi.org/10.18203/2349-2902.isj20170216.
Pełny tekst źródłaSimon, Ole, Georg Beyer, Ujjwal Mahajan i Julia Mayerle. "Pankreaskarzinom 2018 – reif für personalisierte Therapiekonzepte?" TumorDiagnostik & Therapie 40, nr 03 (kwiecień 2019): 180–83. http://dx.doi.org/10.1055/a-0870-8867.
Pełny tekst źródłaChen, Xiaorong, Weibing Leng, YuWen Zhou, Yongyang Yu, Wenjian Meng, Peng Cao, Ziqiang Wang i Meng Qiu. "Pathological response and safety of FOLFOXIRI for neoadjuvant treatment of high-risk relapsed locally advanced colon cancer: study protocol for a single-arm, open-label phase II trial". BMJ Open 13, nr 1 (styczeń 2023): e062659. http://dx.doi.org/10.1136/bmjopen-2022-062659.
Pełny tekst źródłaRaj, Ben, i Madhan Shankar S. R. "Analysis Of Anticancer Activity And Its Molecular Interaction Mechanism Of Withanone, An Active Ingredient Of Withania Somnifera Using Molecular Docking". International Journal of pharma and Bio Sciences 11, nr 6 (30.11.2021): 35–41. http://dx.doi.org/10.22376/ijpbs/lpr.2021.11.6.l35-41.
Pełny tekst źródłaOrtega-García, María Belén, Alberto Mesa, Elisa L. J. Moya, Beatriz Rueda, Gabriel Lopez-Ordoño, Javier Ángel García, Verónica Conde i in. "Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy". Cancers 12, nr 2 (7.02.2020): 379. http://dx.doi.org/10.3390/cancers12020379.
Pełny tekst źródłaSimon, Ole, Georg Beyer, Ujjwal Mahajan i Julia Mayerle. "Pankreaskarzinom 2018 – reif für personalisierte Therapiekonzepte?" DMW - Deutsche Medizinische Wochenschrift 143, nr 15 (30.07.2018): 1109–12. http://dx.doi.org/10.1055/a-0542-4310.
Pełny tekst źródłaBlaschke, Martina, Silke Cameron, Jutta Blumberg, Ulrike Wegner i Giuliano Ramadori. "Measurements of 5-FU levels in plasma of patients with gastrointestinal cancer." Journal of Clinical Oncology 30, nr 4_suppl (1.02.2012): 437. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.437.
Pełny tekst źródłaRoth, Susanne, Christoph Springfeld, Markus K. Diener, Christine Tjaden, Phillip Knebel, Ulla Klaiber, Christoph W. Michalski i in. "Protocol of a prospective, monocentric phase I/II feasibility study investigating the safety of multimodality treatment with a combination of intraoperative chemotherapy and surgical resection in locally confined or borderline resectable pancreatic cancer: the combiCaRe study". BMJ Open 9, nr 8 (sierpień 2019): e028696. http://dx.doi.org/10.1136/bmjopen-2018-028696.
Pełny tekst źródłaMathews, Sunil, Asha T. Jose, Varun Gangwar, Arumugam S. Vadivu i Raghu Nandhan. "Judicious management of pinna keloids: our experience with combination therapy". International Journal of Otorhinolaryngology and Head and Neck Surgery 8, nr 9 (25.08.2022): 729. http://dx.doi.org/10.18203/issn.2454-5929.ijohns20222164.
Pełny tekst źródłaIbrahim, T., P. Serra, B. Vertogen, M. Marangolo i D. Amadori. "Doxorubicin (Dox), cyclophosphamide (Cyc) and weekly docetaxel (Doc) as first-line treatment of advanced breast cancer (ABC)". Journal of Clinical Oncology 25, nr 18_suppl (20.06.2007): 11516. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.11516.
Pełny tekst źródłaStanford, William L., Nicole M. Anderson, Mark D. Minden i Dwayne L. Barber. "Induction of Transient Cytopenia To Analyze Hematopoiesis in Mutant Mice." Blood 106, nr 11 (16.11.2005): 3158. http://dx.doi.org/10.1182/blood.v106.11.3158.3158.
Pełny tekst źródłaYan, Xiaowei, Maolin Hu, Qian Miao, Shun Wang i Kejian Zhao. "The Synthesis and Anticancer Activities of Peptide 5-fluorouracil Derivatives". Journal of Chemical Research 2009, nr 4 (kwiecień 2009): 261–64. http://dx.doi.org/10.3184/030823409x431364.
Pełny tekst źródłaGoncharova, A. S., A. V. Galina, D. V. Khodakova, G. Yu Egorov, A. Yu Maksimov, E. N. Kolesnikov, E. F. Komarova i in. "Inhibition of growth of colorectal cancer patient-derived subcutaneous xenografts using combined Wnt signaling pathway inhibitor and 5‑fluorouracil". Research and Practical Medicine Journal 9, nr 1 (18.02.2022): 33–42. http://dx.doi.org/10.17709/2410-1893-2022-9-1-3.
Pełny tekst źródłaMinchev, Velko T. "Toxic and Adverse Effects of Chemotherapy with 5-Fluoropyrimidine Drugs. Could Dihydropyrimidine Dehydrogenase Enzyme Screening Serve as a Prerequisite to Successful Chemotherapy?" Journal of Biomedical and Clinical Research 13, nr 2 (1.12.2020): 87–99. http://dx.doi.org/10.2478/jbcr-2020-0013.
Pełny tekst źródłaGrabenbauer, Alexander, Thomas Aigner, Holger Göbel, Bernhard J. Leibl, Christof Lamberti, Gerhard G. Grabenbauer i Luitpold V. Distel. "Preoperative Radiochemotherapy in Rectal Cancer: Is There an Impact of Oxaliplatin on Pathologic Complete Response and Survival Rates under “Real World“ Conditions?" Cells 12, nr 3 (22.01.2023): 399. http://dx.doi.org/10.3390/cells12030399.
Pełny tekst źródłaZhu, Ping, Jingping Zhang, Jianfei Zhu, Jun Shi, Qiuwei Zhu i Yuanyuan Gao. "MiR-429 Induces Gastric Carcinoma Cell Apoptosis Through Bcl-2". Cellular Physiology and Biochemistry 37, nr 4 (2015): 1572–80. http://dx.doi.org/10.1159/000438524.
Pełny tekst źródłaFekete, János Tibor, i Balázs Győrffy. "New Transcriptomic Biomarkers of 5-Fluorouracil Resistance". International Journal of Molecular Sciences 24, nr 2 (12.01.2023): 1508. http://dx.doi.org/10.3390/ijms24021508.
Pełny tekst źródłaRoss, Philippa. "Retraction: Facile synthesis of quantum dots/mesoporous silica/quantum dots core/shell/shell hybrid microspheres for ratiometric fluorescence detection of 5-fluorouracil in human serum". Analyst 145, nr 23 (2020): 7766. http://dx.doi.org/10.1039/d0an90114h.
Pełny tekst źródłaGoldstein, Daniel A., Qiushi Chen, Turgay Ayer, David H. Howard, Joseph Lipscomb, Bassel F. El-Rayes i Christopher R. Flowers. "First- and Second-Line Bevacizumab in Addition to Chemotherapy for Metastatic Colorectal Cancer: A United States–Based Cost-Effectiveness Analysis". Journal of Clinical Oncology 33, nr 10 (1.04.2015): 1112–18. http://dx.doi.org/10.1200/jco.2014.58.4904.
Pełny tekst źródłaMedinger, Steinbild i Mross. "Die systemische Therapie des Kolonkarzinoms 2004". Praxis 93, nr 40 (1.09.2004): 1633–44. http://dx.doi.org/10.1024/0369-8394.93.40.1633.
Pełny tekst źródłaTakeuchi, Jaffer A, Fang, Pfeiffer, Takeuchi i van Laarhoven. "Meta-Enrichment Analyses to Identify Advanced Gastric Cancer Patients Who Achieve a Higher Response to S-1/Cisplatin". Cancers 11, nr 6 (21.06.2019): 871. http://dx.doi.org/10.3390/cancers11060871.
Pełny tekst źródłaGoekkurt, Eray, Salah-Eddin Al-Batran, Jörg T. Hartmann, Ulrike Mogck, Gunter Schuch, Michael Kramer, Elke Jaeger, Carsten Bokemeyer, Gerhard Ehninger i Jan Stoehlmacher. "Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie". Journal of Clinical Oncology 27, nr 17 (10.06.2009): 2863–73. http://dx.doi.org/10.1200/jco.2008.19.1718.
Pełny tekst źródłaMa, Yuxiang, Yuehao Lin, Benyan Zou, Wanli Liu, Yang Zhang, Liping Zhao, Yan Huang i in. "Pharmacokinetic and Pharmacodynamic Analyses of 5-Fluorouracil in East-Asian Patients with Nasopharyngeal Carcinoma". Clinical Pharmacokinetics 55, nr 10 (30.04.2016): 1205–16. http://dx.doi.org/10.1007/s40262-016-0395-2.
Pełny tekst źródłaPavithran, Keechilat, Prasanth Ariyannur, Hridya Jayamohanan, Arun Philip, Wesley Mannirathil Jose i Sumi Soman. "Dihydropyrimidine dehydrogenase deficiency in patients treated with 5FU or capecitabine based regimens: A single center experience from South India." Journal of Clinical Oncology 39, nr 15_suppl (20.05.2021): e15517-e15517. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e15517.
Pełny tekst źródłaMarable, Carmen A., Christopher L. Frank, Roland F. Seim, Susan Hester, W. Matthew Henderson, Brian Chorley i Timothy J. Shafer. "Integrated Omic Analyses Identify Pathways and Transcriptomic Regulators Associated With Chemical Alterations of In Vitro Neural Network Formation". Toxicological Sciences 186, nr 1 (20.12.2021): 118–33. http://dx.doi.org/10.1093/toxsci/kfab151.
Pełny tekst źródłaNorman, G., M. Soares, P. Peura, S. Rice, D. Suh, K. Wright, M. Sculpher i A. Eastwood. "Capecitabine for the treatment of advanced gastric cancer". Health Technology Assessment 14, Suppl 2 (październik 2010): 11–17. http://dx.doi.org/10.3310/hta14suppl2-02.
Pełny tekst źródłaYang, Yu, Yuxuan Li i Xiaohui Du. "Does Intraperitoneal Chemotherapy Increase the Incidence of Anastomotic Leakage after Colorectal Cancer Surgery: A Systematic Review and Meta-Analysis". Gastroenterology Research and Practice 2021 (25.01.2021): 1–5. http://dx.doi.org/10.1155/2021/9204373.
Pełny tekst źródłaRaskin, Grigoriy Aleksandrovich, Rashida Vakhidovna Orlova, Anna Eduardovna Protasova, Sergey Aleksandrovich Koshkin i Ruslan Ivanovich Glushakov. "Predictive markers of the efficacy of colon adenocarcinoma treatment by 5-fluoropyrimidines determined by means of immunohistochemistry method". Reviews on Clinical Pharmacology and Drug Therapy 12, nr 4 (15.12.2014): 50–53. http://dx.doi.org/10.17816/rcf12450-53.
Pełny tekst źródłaHeppt, Markus V., Igor Dykukha, Sara Graziadio, Rafael Salido-Vallejo, Matt Chapman-Rounds i Mary Edwards. "Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials". Journal of Clinical Medicine 11, nr 6 (16.03.2022): 1654. http://dx.doi.org/10.3390/jcm11061654.
Pełny tekst źródłaBrasiūnienė, Birutė, i Elona Juozaitytė. "The effect of combined treatment methods on survival and toxicity in patients with pancreatic cancer". Medicina 43, nr 9 (27.09.2007): 716. http://dx.doi.org/10.3390/medicina43090093.
Pełny tekst źródłaBerardi, Rossana, Tiziana Saladino, Davide Mari, Rosa Rita Silva, Mario Scartozzi, Lorena Verdecchia, Azzurra Onofri i Stefano Cascini. "Elderly Patients with Advanced Colorectal Cancer: Tolerability and Activity of Chemotherapy". Tumori Journal 91, nr 6 (listopad 2005): 463–66. http://dx.doi.org/10.1177/030089160509100603.
Pełny tekst źródłaBiambo, A. A., U. M. Aliyu, M. O. Adibe, A. Samaila, N. Usman, K. K. Abubakar i C. V. Ukwe. "Toxicity Profile of Chemotherapeutic Agents among Cancer Patients Receiving Care in a Nigerian Tertiary Health Care Facility." Journal of Basic and Social Pharmacy Research 1, nr 5 (2020): 53–64. http://dx.doi.org/10.52968/27451327.
Pełny tekst źródłaAkushevich, Igor, Arseniy Yashkin, Julia Kravchenko i Miklos Kertai. "Chemotherapy and Anesthesia in Colorectal Cancer Survivors and the Risk of Alzheimer’s Disease". Innovation in Aging 4, Supplement_1 (1.12.2020): 263–64. http://dx.doi.org/10.1093/geroni/igaa057.845.
Pełny tekst źródłaNaito, Masahito, Tomoya Yamamoto, Chikao Shimamoto i Yoshihiro Miwa. "Retrospective Analysis of the Risk Factors for Grade IV Neutropenia in Oesophageal Cancer Patients Treated with a Docetaxel, Cisplatin, and 5-Fluorouracil Regimen". Chemotherapy 62, nr 4 (2017): 215–24. http://dx.doi.org/10.1159/000464273.
Pełny tekst źródłaJia, Yiduo, Yinmeng Zhang i Hong Zhu. "Clindamycin Derivatives: Unveiling New Prospects as Potential Antitumor Agents". Pharmaceuticals 17, nr 3 (22.02.2024): 276. http://dx.doi.org/10.3390/ph17030276.
Pełny tekst źródłaStarenkiy, Viktor, Sergii Artiukh, Mykhaylo Ugryumov, Viktoriia Strilets, Serhii Chernysh i Dmytro Chumachenko. "A Method for Assessing the Risks of Complications in Chemoradiation Treatment of Squamous Cell Carcinoma of the Head and Neck". Open Bioinformatics Journal 14, nr 1 (19.11.2021): 138–43. http://dx.doi.org/10.2174/18750362021140100138.
Pełny tekst źródłaMa, Yuxiang, Yuehao Lin, Benyan Zou, Wanli Liu, Yang Zhang, Liping Zhao, Yan Huang i in. "Correction to: Pharmacokinetic and Pharmacodynamic Analyses of 5-Fluorouracil in East-Asian Patients with Nasopharyngeal Carcinoma". Clinical Pharmacokinetics 57, nr 1 (26.12.2017): 103–4. http://dx.doi.org/10.1007/s40262-017-0615-4.
Pełny tekst źródłaOzaki, Yoshinao, Hirotaka Imamaki, Aki Ikeda, Mitsuaki Oura, Shunsaku Nakagawa, Taro Funakoshi, Shigeki Kataoka i in. "Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses". Cancer Chemotherapy and Pharmacology 86, nr 5 (3.10.2020): 693–99. http://dx.doi.org/10.1007/s00280-020-04158-1.
Pełny tekst źródłaGorneva, Galina, Rada Mateva, Roumyana Gugova i Evgeny Golovinsky. "The study of the apoptogenic effect of pyrimidine derivatives on murine leukemia cells". Archive of Oncology 13, nr 2 (2005): 62–64. http://dx.doi.org/10.2298/aoo0502062g.
Pełny tekst źródłaManuyakorn, Ananya, Rebecca Paulus, James Farrell, Nicole A. Dawson, Sheila Tze, Gardenia Cheung-Lau, Oscar Joe Hines i in. "Cellular Histone Modification Patterns Predict Prognosis and Treatment Response in Resectable Pancreatic Adenocarcinoma: Results From RTOG 9704". Journal of Clinical Oncology 28, nr 8 (10.03.2010): 1358–65. http://dx.doi.org/10.1200/jco.2009.24.5639.
Pełny tekst źródłaSultana, Asma, Catrin Tudur Smith, David Cunningham, Naureen Starling, John P. Neoptolemos i Paula Ghaneh. "Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer". Journal of Clinical Oncology 25, nr 18 (20.06.2007): 2607–15. http://dx.doi.org/10.1200/jco.2006.09.2551.
Pełny tekst źródłaYang, Junjun, Yang Xiang, Xirun Wan, Fengzhi Feng i Tong Ren. "Analysis of the Prognosis and Related Factors for Patients With Stage IV Gestational Trophoblastic Neoplasia". International Journal of Gynecologic Cancer 24, nr 3 (marzec 2014): 594–99. http://dx.doi.org/10.1097/igc.0000000000000070.
Pełny tekst źródłaKubo, Katsumaro, Yuji Murakami, Masahiro Kenjo, Nobuki Imano, Yuki Takeuchi, Ikuno Nishibuchi, Tomoki Kimura i in. "Long-term outcomes of induction chemotherapy followed by chemoradiotherapy using volumetric-modulated arc therapy as an organ preservation approach in patients with stage IVA-B oropharyngeal or hypopharyngeal cancers". Journal of Radiation Research 61, nr 4 (17.06.2020): 554–62. http://dx.doi.org/10.1093/jrr/rraa033.
Pełny tekst źródłaLonardi, S., M. Stefani, A. Jirillo, C. Ghiotto, L. M. Pasetto, C. Falci, E. Lamberti i S. Monfardini. "Benefit of fluorouracil and folinic acid adjuvant in colon cancer elderly patients". Journal of Clinical Oncology 24, nr 18_suppl (20.06.2006): 13564. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.13564.
Pełny tekst źródłaOdin, Elisabeth, Arvid Sondén, Göran Carlsson, Bengt Gustavsson i Yvonne Wettergren. "Folate pathway genes linked to mitochondrial biogenesis and respiration are associated with outcome of patients with stage III colorectal cancer". Tumor Biology 41, nr 6 (czerwiec 2019): 101042831984623. http://dx.doi.org/10.1177/1010428319846231.
Pełny tekst źródła